USPH — U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc. (USPH) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Physical therapy revenues increased by 17.3% year-over-year to $168.3 million.
• Visits: Average visits per clinic per day reached a record 32.7, up from 30.6 in the prior year.
• Net Rate: The net rate per patient visit was $105.33, slightly up from $105.05 year-over-year but down from $105.66 in Q1 2025.
• Adjusted EBITDA: Increased to $26.9 million, up $4.7 million from the previous year, with an adjusted EBITDA margin of 17.5%.
• Gross Profit Margin: Improved to 21.1%, up from 20.1% in the same quarter last year.
• Home Care Visits: 28,493 home care visits reported, stemming from the Metro PT acquisition.

2. Strategic Updates and Business Highlights

• Injury Prevention Partnerships: Revenue from injury prevention (IIP) grew 22.6%, with gross profit up 25.8%. The company is optimistic about future growth in this segment.
• Acquisitions: USPH added over 50 net clinics and expanded its home care business, with plans for further acquisitions.
• Patient Sentiment: The company reported a high Net Promoter Score of 93.5, indicating strong patient satisfaction and referral rates.
• Cost Management: Salaries and related costs increased only 0.7%, the smallest rise since 2023, while overall operating costs per visit decreased.

3. Forward Guidance and Outlook

• Adjusted EBITDA Guidance: Raised to a range of $93 million to $97 million for the full year 2025, reflecting confidence in continued growth.
• De Novo Openings: The company expects to have one of its best years for de novo clinic openings, supported by improved recruitment strategies and staffing initiatives.

4. Challenges and Points of Concern

• Medicare Headwinds: The company faces ongoing challenges from Medicare rate cuts, estimating a $25 million impact on profits due to cumulative reductions over the years.
• Same-Store Growth: Same-store growth in mature facilities was lower than expected, at just over 1%, attributed to staffing challenges and cost control measures.
• Market Competition: The competitive landscape remains challenging, particularly in staffing and recruitment, which could impact future growth if not managed effectively.

5. Notable Q&A Insights

• Demand vs. Staffing: Demand for services is strong, but staffing remains a challenge. The company is focusing on improving recruitment and retention through mentorship and technology.
• AI Integration: USPH is deploying AI tools to streamline clinical documentation, which is expected to enhance efficiency and clinician satisfaction.
• Medicare Rate Increases: Preliminary estimates suggest a potential 1% to 1.75% increase in Medicare rates for 2026, which could provide a modest revenue boost.
• Injury Prevention Segment: The IIP segment is performing ahead of expectations, and the company plans to continue investing in this area for growth.

Overall, USPH reported strong financial performance in Q4 2025, with record patient visits and improved margins, while navigating challenges related to Medicare reimbursement and staffing. The outlook remains positive with raised guidance and strategic growth initiatives in place.